Agency Report A deluge of weight‐loss drugs is set to transform the global fight against obesity as India prepares to unleash low‐cost generic versions of injections like Ozempic after a key patent expired Friday. The move will dramatically widen access to treatments that have long been considered a luxury, especially in middle-income countries, where soaring
Related Articles
Don't miss out on breaking stories and in-depth articles.